Navigation Links
Telik Announces First Quarter 2013 Financial Results
Date:5/10/2013

PALO ALTO, Calif., May 10, 2013 /PRNewswire/ -- Telik, Inc. (Nasdaq: TELK) today reported financial results for the first quarter ended March 31, 2013.  The net loss for the quarter ended March 31, 2013 was $1.9 million, or $0.46 per share, compared with a net loss of $2.3 million, or $1.25 per share, for the same period in 2012. 

Total research and development expenses (R&D) in the first quarter of 2013 were $0.8 million, compared to $1.0 million for the same period in 2012.  The decrease in R&D expenses was primarily due to lower headcount and related costs, and lower clinical development expenditures as a result of cost reduction efforts.

Total general and administrative expenses (G&A) in the first quarter of 2013 were $1.2 million, compared to $1.3 million for the same period in 2012.  The decrease in G&A expenses was primarily due to lower headcount and related expenses, and lower administrative expenses as a result of cost reduction efforts.

Telik is currently focusing on the clinical development of its lead product candidate, TELINTRA® for Myelodysplastic Syndrome (MDS) and other blood disorders. The design of the company's randomized placebo-controlled Phase 3 registration trial of TELINTRA for the treatment of low to intermediate-1 risk MDS using red-blood-cell transfusion independence as the primary endpoint, in accordance with the FDA's guidance, has been completed.  In order to initiate the registration trial, the company is currently looking to secure funding through the establishment of a corporate partnership, funding from a non-profit agency, or other financing sources. 

As of March 31, 2013, cash, cash equivalents and investments totaled $5.6 million, compared with $5.0 million for the quarter ended December 31, 2012.&#
'/>"/>

SOURCE Telik, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Telik Announces the Publication of Two Reports in the Journal Of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Teli
2. Telik Announces Third Quarter 2012 Financial Results
3. Telik Announces Fourth Quarter And 2012 Year End Financial Results And 2013 Financial Guidance
4. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
5. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
6. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
7. Misonix Announces New Distribution Agreement For Panama
8. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
9. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
10. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
11. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... British Columbia and MENLO ... -- DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ... on developing and commercializing proven cancer therapies in ... at the American Association of Cancer Research ... on the potential for its lead product candidate ...
(Date:5/29/2015)... May 29, 2015 Amgen (NASDAQ: ... pivotal Phase 3, global, randomized, placebo-controlled trials evaluating ... of secondary hyperparathyroidism (SHPT) in patients with chronic ... the primary endpoint, demonstrating that a greater proportion ... a greater than 30 percent reduction in parathyroid ...
(Date:5/28/2015)... INDIANAPOLIS , May 28, 2015  Eli Lilly and ... of its previously announced cash tender offer for up to ... debt securities. Holders of notes who tendered, and ... p.m., New York City time, on ... accepted for purchase by Lilly, are eligible to receive the ...
Breaking Medicine Technology:DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 2Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 4Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 5Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 6Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 7Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5
... (NYSE: SHP ) ("ShangPharma" or the ... and development outsourcing company, today announced that it ... for the year ended December 31, 2011 with ... "SEC"). The annual report can be accessed on ...
... JAZZ ) today announced that it will host ... 2012 at 4:30 p.m. EDT/9:30 p.m. IST. During the call, ... review first quarter 2012 results. A live webcast ... of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com ...
Cached Medicine Technology:ShangPharma Corporation Files 2011 Annual Report on Form 20-F 2
(Date:5/29/2015)... Diego, California (PRWEB) May 29, 2015 A ... Core” and have joined the national effort to teach this ... parents in the U.S. have been “sickened” by the recent ... However, love it or hate it, Common Core is now ... District of Columbia. Parents are now seeking ways to ...
(Date:5/29/2015)... The print component of “Skin Health” is ... 250,000 and an estimated readership of 750,000. The digital ... strategy, and across a network of top news sites ... the campaign, click here. , Lucy Liu ... actress, model and producer details her skin care routine, ...
(Date:5/29/2015)... Chicago, Ill (PRWEB) May 29, 2015 ... Care , a dozen medical pioneers recognized by a ... changed the course of cancer treatment. Honorees will be ... of Cancer Care™ Award Ceremony, held 8:30-11:00 p.m. CDT ... , The 2015 honorees are being recognized for groundbreaking ...
(Date:5/29/2015)... Oaksterdam University, the first cannabis college in America, will ... popular and highly demanded Basic and Advanced Classic Seminars ... to 5:30 pm each day. Certification is available upon completion of ... held on June 14 from 12:00 pm to 6:00 pm. Both ... Plaza Hotel & Casino in downtown Las Vegas. , ...
(Date:5/29/2015)... Designed with the versatile athlete in mind, ... all new, exclusive line of supplementation called The 24/7 ... and greatest, high impact, result driven ingredients that have ... 24/7 Series can be used by anyone from bodybuilders ... fitness enthusiasts. There are no stimulant based ingredients that ...
Breaking Medicine News(10 mins):Health News:Doctors Discover a Cure for the Common Core 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 3Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 4Health News:Oaksterdam University to Host Educational Cannabis Seminars and Job Fair in Las Vegas June 12 to 15; Training For Those Wanting To Work in Legal Cannabis Industry 2Health News:Oaksterdam University to Host Educational Cannabis Seminars and Job Fair in Las Vegas June 12 to 15; Training For Those Wanting To Work in Legal Cannabis Industry 3Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 3
... seen with cirrohosis but aren,t sensitive enough , , ... to detect esophageal bleeding in people with cirrhosis show ... researchers. , About 25 percent of patients with cirrhosis ... veins commonly seen with cirrhosis. Variceal bleeding can cause ...
... movement, serious complications can follow, experts note , , TUESDAY, ... identified a marker that might predict which pregnant women ... essentially a baby,s first bowel movement, excreted in the ... is considered a sign of fetal distress. A small ...
... London, New Delhi, and Singapore (6 May, 2008) ... manage patients with depression has challenged the rationale behind ... behavioural therapy (CBT) for milder depression. , According ... is a lack of evidence for CBT being more ...
... with state and local public health agencies for,Community ... The Community Coalitions Health,Institute (CCHI), a 501(c)(3) affiliate ... that it has received a five-year grant from ... improvement in,community health systems across the country. The ...
... WHAT: On national grassroots lobby day, Lance Armstrong to visit four ... * TUESDAY, MAY 13, 2008 WHERE: Tour of Ralph ... (RLC) and RLC Fifth Anniversary Celebration at the Marcus ... 1919 Madison Avenue (Entrance on 124th Street) ...
... WASHINGTON, May 6 The latest,"gaming for health" ... games (e.g., a "disease" being unleashed inadvertently,on the ... videogames,used to train emergency medical personnel -- will ... event at 1 p.m. EDT Thursday,(May 8, 2008)., ...
Cached Medicine News:Health News:Noninvasive Procedures Show Promise for Esophageal Bleeding 2Health News:Doctors Discover Marker for Meconium Passage During Delivery 2Health News:Antidepressants do work in depression while evidence for CBT is poorer say experts 2Health News:Antidepressants do work in depression while evidence for CBT is poorer say experts 3Health News:NBCH's Community Coalitions Health Institute Receives CDC Grant 2Health News:Lance Armstrong Marks 5th Annual LIVESTRONG(TM) Day with Nationwide Fly-Around 2Health News:Video Gaming for Health: Major New Trends to Be Discussed as National Conference Gets Underway 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: